Building an Asian medical hub to bolster the Shanghai Brand
Over the last 40 years, Shanghai has become an engine for international economic cooperation and competition, serving as a powerful driver for the Chinese economy and an alluring gateway for the international community. Launching the Shanghai Brand as a symbol of the city’s dynamics and appeal offers a clear framework for the city’s twin goals: reform and opening up, and high-quality development.
This strategy has been articulated through critical policies such as the Opinions on Developing Shanghai’s Four Major Brands and Leading High-Quality Development, and the 2018 Shanghai Government Work Report. Moreover, as outlined in the Healthy Shanghai 2030 plan, Shanghai’s long-term vision of becoming a globally competitive health science and innovation center further underlines the great importance of health for the city’s future. Leveraging Shanghai’s exceptional resources to build a globally competitive Shanghai Brand should be the city’s priority in reinforcing its competitive edge and deepening reform and opening up.
From our perspective, making Shanghai a medical hub in Asia with a world-class health care sector and a prosperous biomedical industry will significantly increase the city’s influence and reinforce its strategic advantage and global competitiveness.
Meeting the health care needs of its residents is one of the core functions for a city and also an important factor in increasing its service capacity and influence. In recent years, health care has become increasingly important worldwide. In China, it has been elevated to the level of a national strategy. In particular, the national “Healthy China” initiative, the recent comments on the health care industry by Premier Li Keqiang, and the policies encouraging the development of therapies for cancer and rare diseases have demonstrated the government’s determination to improve the overall health of the citizens. However, there are still many unmet medical needs in China and many other Asian countries, and there is a clear gap in health care between people in those countries and their counterparts in developed countries. Therefore, making Shanghai a medical hub in Asia to address the unmet medical needs in the region would contribute to Shanghai’s effort to increase its influence and advance the Shanghai Brand.
In order to support Shanghai in its effort to become a medical hub in Asia, to play a leading role in health care innovation, and to realize the goals set out in Healthy Shanghai 2030, Roche advises that Shanghai do the following three things as a priority: to foster international collaboration and promote the adoption of Internet+ technologies such as artificial intelligence (AI) and big data in clinical practice.
The CEDTSD will enable Shanghai to take a leading role in implementing the national strategy for special diseases and fulfill its duty as a pioneer and forerunner in China.